Circ_0000745 Promotes the Progression of Cervical Cancer by Regulating miR-409-3p/ATF1 Axis-Reference-Cited by-同舟云学术

Circ_0000745 Promotes the Progression of Cervical Cancer by Regulating miR-409-3p/ATF1 Axis

Published:2020-07-09 Issue: Volume: Page:
ISSN:1084-9785
Container-title:Cancer Biotherapy and Radiopharmaceuticals
language:en
Short-container-title:Cancer Biotherapy and Radiopharmaceuticals

Author:

Cui Xia¹,Chen Jiming¹,Zheng Yafeng¹,Shen Huaji¹

Affiliation:

1. Department of Gynecology, Changzhou No. 2 People's Hospital Affiliated to Nanjing Medical University, Changzhou, China.

Publisher

Mary Ann Liebert Inc

Subject

Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

https://www.liebertpub.com/doi/pdf/10.1089/cbr.2019.3392

Reference40 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cervical cancer

3. Human Papillomavirus Testing in the Prevention of Cervical Cancer

4. Nodal-staging surgery for locally advanced cervical cancer in the era of PET

5. The biogenesis, biology and characterization of circular RNAs

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ATF family members as therapeutic targets in cancer: From mechanisms to pharmacological interventions;Pharmacological Research;2024-10

2. MicroRNA-409: Molecular functions and clinical applications in cancer;Biochemistry and Biophysics Reports;2024-07

3. Investigating the molecular mechanisms of microRNA‑409‑3p in tumor progression: Towards targeted therapeutics (Review);International Journal of Oncology;2024-05-16

4. Environmental cadmium-induced circRNA-miRNA-mRNA network regulatory mechanism in human normal liver cell model;Current Research in Toxicology;2024

5. circ_0000337 Promotes the Progression of Cervical Cancer by miR-155-5p/RAB3B Axis;Biochemical Genetics;2023-10-26